R-Biopharm awarded USDA vomitoxin testing contract

by Emily Buckley
Share This:

MARSHALL, MICHIGAN, U.S. — The U.S. Department of Agriculture, Grain Inspection Packers and Stockyards Administration has awarded R-Biopharm, Inc. a contract for vomitoxin (deoxynivalenol) testing. The USDA’s Federal Grain Inspection Service (FGIS) will utilize the company’s quantitative test to monitor the U.S. grain supply, primarily wheat, barley and corn for vomitoxin. The contract will be for one year, with four one-year renewal options. The award calls for exclusive use of R-Biopharm’s test kit at all 27 GIPSA laboratory locations.

Deoxynivalenol (DON), a toxin produced by fusarium graminearum, occurs in barley and other feed grains when grown under certain climatic conditions. The quality of beer can be adversely affected when malting barley with significant concentrations of DON are used. Illnesses have been observed in livestock that have consumed feed grains containing high levels of DON concentrations. As a consequence, wheat and barley lots often receive price discounts when DON concentrations exceed certain levels.

R-Biopharm develops, manufactures, and markets rapid enzyme immunoassays for the detection of residues in food and feed. They include test kits for the screening of mycotoxins, hormones and anabolics, antibiotics, vitamins, food allergens and other parameters. R-Biopharm is also the worldwide exclusive distributor for the Boehringer Mannheim Roche enzymatic tests as well as PCR based tests for the detection of GMOs and allergens by CONGEN.

R-Biopharm, Inc. is a member of the R-Biopharm Group with headquarters in Darmstadt, Germany.